Nuvo Pharmaceuticals Acquisition of the Canadian business and the Vimovo assets of Aralez Pharmaceuticals
Goodmans LLP acted as counsel to Nuvo in connection with its purchase of the shares of Aralez Pharmaceuticals Canada Inc. (“Aralez Canada”) and certain assets of its US affiliate related to Vimovo. Aralez Pharmaceuticals Inc. and Aralez Canada (“Aralez”) sought and obtained protection from their creditors under the CCAA on August 10, 2018, in a filing before the Ontario Superior Court of Justice (Commercial List). On the same day, certain Aralez entities filed for protection from their creditors under Chapter 11 of the U.S. Bankruptcy Code before the United States Bankruptcy Court for the Southern District of New York. Deerfield is the senior secured lender and DIP lender to Aralez.
At the outset of the coordinated bankruptcy proceedings, Aralez announced its intention to enter into certain stalking-horse agreements and pursue a sale process for its assets and subsequently entered into and received Court approval of stalking horse agreements for each of: (i) its Canadian business; (ii) its Vimovo assets; and (iii) its Toprol assets.
Goodmans acted as counsel to Nuvo with respect to the purchase of the Canadian business and the Vimovo assets. A coordinated sale process approved by each of the Canadian and U.S. courts was pursued by Aralez with Nuvo ultimately being declared the successful bidder in respect of the Canadian business and the Vimovo assets. Sale approval is scheduled for December 4, 2018, in the U.S., and December 7, 2018, in Canada. The financing for the purchase is being provided by Deerfield and involves a combination of loans, convertible debentures and warrants issued by the Irish and Canadian entities respectively. The transactions are expected to close by the end of 2018.
The matter is unique as it involved a coordinated sale process between the Canadian and U.S. Courts. In addition, it is contemplated that the purchase of the Canadian business will occur via a share purchase with Canadian unsecured creditors being unimpaired. The financing is a unique multi-layered financing consisting of an Irish amortizing loan, a Canadian convertible loan and equity warrants in Nuvo.
Featured Work
-
Restructuring
Endo International plc completes global restructuring
Goodmans LLP acted as Canadian legal counsel to the Endo Group (or the “Company”) in connection with its restructuring initiatives, transaction matters, negotiated resolutions with Canadian… -
Restructuring
Xplore completes CBCA recapitalization and restructures satellite business through RVO
Goodmans LLP acted as Canadian legal counsel to Xplore Inc. in connection with its recapitalization, restructuring, financing, regulatory, governance and business initiatives, including its review of… -
Restructuring
WeWork’s restructuring proceedings
Goodmans LLP acted as Canadian legal counsel to WeWork Inc. in connection with its restructuring initiatives, the Canadian Part IV CCAA proceedings, and issues affecting Canadian stakeholders… -
Restructuring
Comark Group’s restructuring proceedings
Goodmans LLP is counsel for Alvarez & Marsal Canada Inc. in its capacity as court-appointed monitor in the recognition proceedings of Comark Group under the Companies’ Creditors Arrangement Act… -
Restructuring
Tacora Resources Inc.’s CCAA restructuring
Goodmans LLP acted as counsel to Cargill, Incorporated and Cargill International Trading Pte Ltd. (collectively “Cargill”), in connection with the restructuring proceedings of Tacora Resources Inc… -
Restructuring
Contract Pharmaceuticals CCAA proceedings and sale to Aterian Investment Partners
Goodmans LLP acted as counsel to Contract Pharmaceuticals Limited and its affiliates in connection with their CCAA proceedings and other restructuring…